Read more
April 2024
Caristo’s CaRi-Heart® AI Technology used to monitor effects of Orticumab detected a reduction in coronary inflammation and predicted a 50%…
Read more
March 2024
UK-wide radiologist network to deploy Caristo’s pioneering CaRi-Heart® solution Oxford, March 19, 2024— Heart & Lung Health (HLH), a UK-wide network of…
Read more
March 2024
Cardiovascular risk prediction models based on traditional risk factors underestimate risk in women – review article by European Atherosclerosis Society…
Read more
January 2024
Press Release Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment (LODOCO®– colchicine, 0.5 mg…
Read more
November 2023
Press Release Caristo’s AI Technology for Coronary Inflammation Measurement and Risk Assessment Can Transform Risk Stratification and Management of Patients…
Read more
September 2023
Press Release British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day CaRi-Heart®…
Read more
August 2023
The health care startup scene in Oxford, Oxfordshire, United Kingdom, is thriving with innovative companies that are making a significant…
Read more
August 2023
The new pilot supported by NHS England will involve five NHS trusts, including University Hospitals of Leicester NHS Trust, Liverpool…
Get in touch for more information.
